New User? Sign Up | Sign In

Insider Trading - GADICKE ANSBERT

Select Time period:

Enter Stock Symbol or Cik: Cik Lookup...

Search By Company or Insider Name:
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

Email a friend >>...

SPAC List: List of Special Purpose Acquisition Companies

Insider Trading Transactions for GADICKE ANSBERT

Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2017-10-10
Purchase
2017-10-11
2:25 pm
RHYTHM PHARMACEUTICALS Inc RYTM MPM BIOVENTURES V L.P.
EVNIN LUKE
GADICKE ANSBERT
MPM ASSET MANAGEMENT INVESTORS BV5 LLC
MPM BIOVENTURES V GP LLC
MPM BIOVENTURES V LLC
10% Owner
100,000 $17 $1,700,000 2,696,392
(Indirect)
View
2019-02-12
Purchase
2019-02-14
5:28 pm
Harpoon Therapeutics Inc. HARP GADICKE ANSBERT
10% Owner
500,000 $14 $7,000,000 8,422,847
(Indirect)
View
2019-02-12
Sale
2019-02-14
5:28 pm
Harpoon Therapeutics Inc. HARP GADICKE ANSBERT
10% Owner
1,971 $14 $27,594 8,422,847
(Indirect)
View
2019-02-19
Purchase
2019-02-21
4:52 pm
TCR2 THERAPEUTICS Inc TCRR GADICKE ANSBERT
Director
10% Owner
1,373,333 $15 $20,599,995 1,569,235
(Indirect)
View
2020-06-23
Purchase
2020-06-25
4:33 pm
Repare Therapeutics Inc. RPTX GADICKE ANSBERT
10% Owner
500,000 $20 $10,000,000 5,392,109
(Indirect)
View
2020-07-28
Purchase
2020-07-30
08:00 am
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
320,000 $19 $6,080,000 2,355,557
(Indirect)
View
2020-10-06
Purchase
2020-10-08
6:28 pm
Oncorus Inc. ONCR GADICKE ANSBERT
10% Owner
325,000 $15 $4,875,000 2,377,025
(Indirect)
View
2021-01-12
Purchase
2021-01-14
5:51 pm
Cullinan Management Inc. CGEM GADICKE ANSBERT
Director
10% Owner
300,000 $21 $6,300,000 7,913,887
(Indirect
Direct)
View
2021-01-20
Sale
2021-01-22
8:16 pm
Harpoon Therapeutics Inc. HARP MPM BioVentures 2014 L.P.
MPM ASSET MANAGEMENT LLC
MPM BioVentures 2014 (B) L.P.
MPM Asset Management Investors BV2014 LLC
MPM BioVentures 2014 LLC
MPM BioVentures 2014 GP LLC
Foley Todd
GADICKE ANSBERT
EVNIN LUKE
10% Owner
68,455 $22.51 $1,540,761 4,354,324
(Indirect)
View
2021-01-25
Sale
2021-01-27
8:35 pm
Harpoon Therapeutics Inc. HARP MPM BioVentures 2014 L.P.
MPM ASSET MANAGEMENT LLC
MPM BioVentures 2014 (B) L.P.
MPM Asset Management Investors BV2014 LLC
MPM BioVentures 2014 LLC
MPM BioVentures 2014 GP LLC
Foley Todd
GADICKE ANSBERT
EVNIN LUKE
10% Owner
721,194 $20.02 $14,441,349 3,633,130
(Indirect)
View
2021-02-02
Sale
2021-02-04
7:30 pm
Harpoon Therapeutics Inc. HARP MPM BioVentures 2014 L.P.
MPM ASSET MANAGEMENT LLC
MPM BioVentures 2014 (B) L.P.
MPM Asset Management Investors BV2014 LLC
MPM BioVentures 2014 LLC
MPM BioVentures 2014 GP LLC
Foley Todd
GADICKE ANSBERT
EVNIN LUKE
10% Owner
120,073 $20.22 $2,427,558 3,513,057
(Indirect)
View
2021-02-05
Sale
2021-02-09
6:14 pm
Harpoon Therapeutics Inc. HARP MPM BioVentures 2014 L.P.
MPM ASSET MANAGEMENT LLC
MPM BioVentures 2014 (B) L.P.
MPM Asset Management Investors BV2014 LLC
MPM BioVentures 2014 LLC
MPM BioVentures 2014 GP LLC
Foley Todd
GADICKE ANSBERT
EVNIN LUKE
10% Owner
91,700 $20.06 $1,839,337 3,421,357
(Indirect)
View
2021-02-10
Sale
2021-02-12
5:03 pm
Harpoon Therapeutics Inc. HARP MPM BioVentures 2014 L.P.
MPM ASSET MANAGEMENT LLC
MPM BioVentures 2014 (B) L.P.
MPM Asset Management Investors BV2014 LLC
MPM BioVentures 2014 LLC
MPM BioVentures 2014 GP LLC
Foley Todd
GADICKE ANSBERT
EVNIN LUKE
10% Owner
183,051 $20 $3,661,020 3,238,306
(Indirect)
View
2021-03-12
Sale
2021-03-15
5:10 pm
Repare Therapeutics Inc. RPTX GADICKE ANSBERT
10% Owner
695,000 $28.18 $19,585,100 4,697,109
(Indirect)
View
2021-04-07
Sale
2021-04-09
4:47 pm
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management GP LLC
10% Owner
41,982 $30.99 $1,300,850 6,004,568
(Indirect)
View
2021-04-09
Sale
2021-04-13
4:13 pm
Harpoon Therapeutics Inc. HARP GADICKE ANSBERT
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Impact Management GP LLC
UBS Oncology Impact Fund L.P.
10% Owner
30,928 $21.9 $677,357 7,105,800
(Indirect)
View
2021-04-09
Sale
2021-04-13
4:15 pm
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management GP LLC
10% Owner
200 $29.99 $5,998 6,004,368
(Indirect)
View
2021-04-13
Sale
2021-04-15
8:00 pm
Harpoon Therapeutics Inc. HARP GADICKE ANSBERT
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Impact Management GP LLC
UBS Oncology Impact Fund L.P.
10% Owner
38,556 $20.16 $777,359 7,067,244
(Indirect)
View
2021-04-16
Sale
2021-04-20
6:07 pm
Harpoon Therapeutics Inc. HARP GADICKE ANSBERT
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Impact Management GP LLC
UBS Oncology Impact Fund L.P.
10% Owner
38,152 $19.04 $726,550 7,029,092
(Indirect)
View
2021-04-21
Sale
2021-04-22
4:04 pm
Harpoon Therapeutics Inc. HARP GADICKE ANSBERT
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Impact Management GP LLC
UBS Oncology Impact Fund L.P.
10% Owner
8,972 $18.97 $170,229 7,020,120
(Indirect)
View
2021-04-27
Sale
2021-04-29
5:46 pm
Harpoon Therapeutics Inc. HARP GADICKE ANSBERT
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Impact Management GP LLC
UBS Oncology Impact Fund L.P.
10% Owner
130,143 $21.99 $2,861,368 6,889,977
(Indirect)
View
2021-04-30
Sale
2021-05-04
5:43 pm
Harpoon Therapeutics Inc. HARP GADICKE ANSBERT
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Impact Management GP LLC
UBS Oncology Impact Fund L.P.
10% Owner
328,519 $22.48 $7,386,435 6,561,458
(Indirect)
View
2021-05-05
Sale
2021-05-06
4:05 pm
Harpoon Therapeutics Inc. HARP GADICKE ANSBERT
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Impact Management GP LLC
UBS Oncology Impact Fund L.P.
10% Owner
10,172 $22.52 $229,107 6,551,286
(Indirect)
View
2021-05-04
Purchase
2021-05-06
4:19 pm
Werewolf Therapeutics Inc. HOWL GADICKE ANSBERT
MPM ONCOLOGY INNOVATIONS FUND LP
UBS Oncology Impact Fund L.P.
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Innovations Fund GP LLC
MPM Oncology Impact Management GP LLC
10% Owner
245,000 $16 $3,920,000 6,672,183
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2016-05-24
Option Award
2016-06-02
10:00 am
N/A
2026-03-08
Radius Health Inc. RDUS GADICKE ANSBERT
Director
27,500 $0 27,500
(Direct)
View
2016-06-09
Option Award
2016-06-13
08:24 am
N/A
2026-06-09
CHIASMA INC CHMA GADICKE ANSBERT
Director
10,000 $0 10,000
(Direct)
View
2016-09-27
Other
2016-09-29
6:05 pm
N/A
N/A
Radius Health Inc. RDUS GADICKE ANSBERT
Director
1,943,751 $0 3,887,502
(Indirect)
View
2017-02-17
Option Award
2017-02-22
4:25 pm
N/A
2027-02-16
Radius Health Inc. RDUS GADICKE ANSBERT
Director
27,500 $0 27,500
(Direct)
View
2017-10-10
Conversion
2017-10-11
2:25 pm
N/A
N/A
RHYTHM PHARMACEUTICALS Inc RYTM MPM BIOVENTURES V L.P.
EVNIN LUKE
GADICKE ANSBERT
MPM ASSET MANAGEMENT INVESTORS BV5 LLC
MPM BIOVENTURES V GP LLC
MPM BIOVENTURES V LLC
10% Owner
2,567,014 $0 2,596,392
(Indirect)
View
2017-10-10
Conversion
2017-10-11
2:25 pm
N/A
N/A
RHYTHM PHARMACEUTICALS Inc RYTM MPM BIOVENTURES V L.P.
EVNIN LUKE
GADICKE ANSBERT
MPM ASSET MANAGEMENT INVESTORS BV5 LLC
MPM BIOVENTURES V GP LLC
MPM BIOVENTURES V LLC
10% Owner
7,651,831 $0 0
(Indirect)
View
2017-10-10
Conversion
2017-10-11
2:25 pm
N/A
N/A
RHYTHM PHARMACEUTICALS Inc RYTM MPM BIOVENTURES V L.P.
EVNIN LUKE
GADICKE ANSBERT
MPM ASSET MANAGEMENT INVESTORS BV5 LLC
MPM BIOVENTURES V GP LLC
MPM BIOVENTURES V LLC
10% Owner
15,887,703 $0 0
(Indirect)
View
2019-02-12
Conversion
2019-02-14
5:28 pm
N/A
N/A
Harpoon Therapeutics Inc. HARP GADICKE ANSBERT
10% Owner
3,050,329 $0 3,372,392
(Indirect)
View
2019-02-12
Conversion
2019-02-14
5:28 pm
N/A
N/A
Harpoon Therapeutics Inc. HARP GADICKE ANSBERT
10% Owner
3,157,506 $0 6,529,898
(Indirect)
View
2019-02-12
Conversion
2019-02-14
5:28 pm
N/A
N/A
Harpoon Therapeutics Inc. HARP GADICKE ANSBERT
10% Owner
835,705 $0 7,365,603
(Indirect)
View
2019-02-12
Exercise
2019-02-14
5:28 pm
N/A
N/A
Harpoon Therapeutics Inc. HARP GADICKE ANSBERT
10% Owner
559,215 $0.0492 7,924,818
(Indirect)
View
2019-02-12
Conversion
2019-02-14
5:28 pm
N/A
N/A
Harpoon Therapeutics Inc. HARP GADICKE ANSBERT
10% Owner
3,050,329 $0 0
(Indirect)
View
2019-02-12
Conversion
2019-02-14
5:28 pm
N/A
N/A
Harpoon Therapeutics Inc. HARP GADICKE ANSBERT
10% Owner
3,157,506 $0 0
(Indirect)
View
2019-02-12
Conversion
2019-02-14
5:28 pm
N/A
N/A
Harpoon Therapeutics Inc. HARP GADICKE ANSBERT
10% Owner
835,705 $0 0
(Indirect)
View
2019-02-12
Exercise
2019-02-14
5:28 pm
2015-03-23
2025-03-24
Harpoon Therapeutics Inc. HARP GADICKE ANSBERT
10% Owner
25,418 $0 0
(Indirect)
View
2019-02-12
Exercise
2019-02-14
5:28 pm
2015-07-23
2025-07-23
Harpoon Therapeutics Inc. HARP GADICKE ANSBERT
10% Owner
57,192 $0 0
(Indirect)
View
2019-02-12
Exercise
2019-02-14
5:28 pm
2015-08-19
2025-08-19
Harpoon Therapeutics Inc. HARP GADICKE ANSBERT
10% Owner
171,579 $0 0
(Indirect)
View
2019-02-12
Exercise
2019-02-14
5:28 pm
2015-12-16
2025-12-16
Harpoon Therapeutics Inc. HARP GADICKE ANSBERT
10% Owner
50,837 $0 0
(Indirect)
View
2019-02-12
Exercise
2019-02-14
5:28 pm
2016-11-01
2026-11-01
Harpoon Therapeutics Inc. HARP GADICKE ANSBERT
10% Owner
152,514 $0 0
(Indirect)
View
2019-02-12
Exercise
2019-02-14
5:28 pm
2017-01-10
2027-01-10
Harpoon Therapeutics Inc. HARP GADICKE ANSBERT
10% Owner
101,675 $0 0
(Indirect)
View
2019-02-19
Conversion
2019-02-21
4:52 pm
N/A
N/A
TCR2 THERAPEUTICS Inc TCRR GADICKE ANSBERT
Director
10% Owner
79,644 $0 79,644
(Indirect)
View
2019-02-19
Conversion
2019-02-21
4:52 pm
N/A
N/A
TCR2 THERAPEUTICS Inc TCRR GADICKE ANSBERT
Director
10% Owner
52,469 $0 52,469
(Indirect)
View
2019-02-19
Conversion
2019-02-21
4:52 pm
N/A
N/A
TCR2 THERAPEUTICS Inc TCRR GADICKE ANSBERT
Director
10% Owner
146,447 $0 146,447
(Indirect)
View
2019-02-19
Conversion
2019-02-21
4:52 pm
N/A
N/A
TCR2 THERAPEUTICS Inc TCRR GADICKE ANSBERT
Director
10% Owner
2,195,681 $0 2,195,681
(Indirect)
View
2019-02-19
Conversion
2019-02-21
4:52 pm
N/A
N/A
TCR2 THERAPEUTICS Inc TCRR GADICKE ANSBERT
Director
10% Owner
351,155 $0 351,155
(Indirect)
View
2019-02-19
Conversion
2019-02-21
4:52 pm
N/A
N/A
TCR2 THERAPEUTICS Inc TCRR GADICKE ANSBERT
Director
10% Owner
2,421,775 $0 2,421,775
(Indirect)
View
2019-02-19
Conversion
2019-02-21
4:52 pm
N/A
N/A
TCR2 THERAPEUTICS Inc TCRR GADICKE ANSBERT
Director
10% Owner
9,291 $0 88,935
(Indirect)
View
2019-02-19
Conversion
2019-02-21
4:52 pm
N/A
N/A
TCR2 THERAPEUTICS Inc TCRR GADICKE ANSBERT
Director
10% Owner
5,247 $0 57,716
(Indirect)
View
2019-02-19
Conversion
2019-02-21
4:52 pm
N/A
N/A
TCR2 THERAPEUTICS Inc TCRR GADICKE ANSBERT
Director
10% Owner
17,085 $0 163,532
(Indirect)
View
2019-02-19
Conversion
2019-02-21
4:52 pm
N/A
N/A
TCR2 THERAPEUTICS Inc TCRR GADICKE ANSBERT
Director
10% Owner
256,163 $0 2,451,844
(Indirect)
View
2019-02-19
Conversion
2019-02-21
4:52 pm
N/A
N/A
TCR2 THERAPEUTICS Inc TCRR GADICKE ANSBERT
Director
10% Owner
35,115 $0 386,270
(Indirect)
View
2019-02-19
Conversion
2019-02-21
4:52 pm
N/A
N/A
TCR2 THERAPEUTICS Inc TCRR GADICKE ANSBERT
Director
10% Owner
282,540 $0 2,704,315
(Indirect)
View
2019-02-19
Conversion
2019-02-21
4:52 pm
N/A
N/A
TCR2 THERAPEUTICS Inc TCRR GADICKE ANSBERT
Director
10% Owner
493,306 $0 0
(Indirect)
View
2019-02-19
Conversion
2019-02-21
4:52 pm
N/A
N/A
TCR2 THERAPEUTICS Inc TCRR GADICKE ANSBERT
Director
10% Owner
325,002 $0 0
(Indirect)
View
2019-02-19
Conversion
2019-02-21
4:52 pm
N/A
N/A
TCR2 THERAPEUTICS Inc TCRR GADICKE ANSBERT
Director
10% Owner
907,073 $0 0
(Indirect)
View
2019-02-19
Conversion
2019-02-21
4:52 pm
N/A
N/A
TCR2 THERAPEUTICS Inc TCRR GADICKE ANSBERT
Director
10% Owner
13,599,621 $0 0
(Indirect)
View
2019-02-19
Conversion
2019-02-21
4:52 pm
N/A
N/A
TCR2 THERAPEUTICS Inc TCRR GADICKE ANSBERT
Director
10% Owner
2,174,998 $0 0
(Indirect)
View
2019-02-19
Conversion
2019-02-21
4:52 pm
N/A
N/A
TCR2 THERAPEUTICS Inc TCRR GADICKE ANSBERT
Director
10% Owner
15,000,000 $0 0
(Indirect)
View
2019-02-19
Conversion
2019-02-21
4:52 pm
N/A
N/A
TCR2 THERAPEUTICS Inc TCRR GADICKE ANSBERT
Director
10% Owner
57,552 $0 0
(Indirect)
View
2019-02-19
Conversion
2019-02-21
4:52 pm
N/A
N/A
TCR2 THERAPEUTICS Inc TCRR GADICKE ANSBERT
Director
10% Owner
32,500 $0 0
(Indirect)
View
2019-02-19
Conversion
2019-02-21
4:52 pm
N/A
N/A
TCR2 THERAPEUTICS Inc TCRR GADICKE ANSBERT
Director
10% Owner
105,825 $0 0
(Indirect)
View
2019-02-19
Conversion
2019-02-21
4:52 pm
N/A
N/A
TCR2 THERAPEUTICS Inc TCRR GADICKE ANSBERT
Director
10% Owner
1,586,623 $0 0
(Indirect)
View
2019-02-19
Conversion
2019-02-21
4:52 pm
N/A
N/A
TCR2 THERAPEUTICS Inc TCRR GADICKE ANSBERT
Director
10% Owner
217,500 $0 0
(Indirect)
View
2019-02-19
Conversion
2019-02-21
4:52 pm
N/A
N/A
TCR2 THERAPEUTICS Inc TCRR GADICKE ANSBERT
Director
10% Owner
1,750,000 $0 0
(Indirect)
View
2020-06-23
Conversion
2020-06-25
4:33 pm
N/A
N/A
Repare Therapeutics Inc. RPTX GADICKE ANSBERT
10% Owner
3,603,161 $0 3,603,161
(Indirect)
View
2020-06-23
Conversion
2020-06-25
4:33 pm
N/A
N/A
Repare Therapeutics Inc. RPTX GADICKE ANSBERT
10% Owner
1,288,948 $0 4,892,109
(Indirect)
View
2020-06-23
Conversion
2020-06-25
4:33 pm
N/A
N/A
Repare Therapeutics Inc. RPTX GADICKE ANSBERT
10% Owner
3,603,161 $0 0
(Indirect)
View
2020-06-23
Conversion
2020-06-25
4:33 pm
N/A
N/A
Repare Therapeutics Inc. RPTX GADICKE ANSBERT
10% Owner
1,288,948 $0 0
(Indirect)
View
2020-07-23
Option Award
2020-07-24
7:20 pm
N/A
2030-07-23
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
Director
10% Owner
16,608 $0 0
(Direct)
View
2020-07-28
Conversion
2020-07-30
08:00 am
N/A
N/A
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
1,269,230 $0 1,269,230
(Indirect)
View
2020-07-28
Conversion
2020-07-30
08:00 am
N/A
N/A
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
84,655 $0 84,655
(Indirect)
View
2020-07-28
Conversion
2020-07-30
08:00 am
N/A
N/A
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
43,687 $0 43,687
(Indirect)
View
2020-07-28
Conversion
2020-07-30
08:00 am
N/A
N/A
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
801,619 $0 801,619
(Indirect)
View
2020-07-28
Conversion
2020-07-30
08:00 am
N/A
N/A
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
42,605 $0 42,605
(Indirect)
View
2020-07-28
Conversion
2020-07-30
08:00 am
N/A
N/A
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
15,820 $0 15,820
(Indirect)
View
2020-07-28
Conversion
2020-07-30
08:00 am
N/A
N/A
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
1,397,574 $0 1,397,574
(Indirect)
View
2020-07-28
Conversion
2020-07-30
08:00 am
N/A
N/A
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
724,702 $0 1,993,932
(Indirect)
View
2020-07-28
Conversion
2020-07-30
08:00 am
N/A
N/A
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
48,336 $0 132,991
(Indirect)
View
2020-07-28
Conversion
2020-07-30
08:00 am
N/A
N/A
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
24,944 $0 68,381
(Indirect)
View
2020-07-28
Conversion
2020-07-30
08:00 am
N/A
N/A
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
457,706 $0 1,259,325
(Indirect)
View
2020-07-28
Conversion
2020-07-30
08:00 am
N/A
N/A
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
24,326 $0 66,931
(Indirect)
View
2020-07-28
Conversion
2020-07-30
08:00 am
N/A
N/A
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
9,033 $0 24,853
(Indirect)
View
2020-07-28
Conversion
2020-07-30
08:00 am
N/A
N/A
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
797,983 $0 2,195,557
(Indirect)
View
2020-07-28
Conversion
2020-07-30
08:00 am
N/A
N/A
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
3,824,591 $0 0
(Indirect)
View
2020-07-28
Conversion
2020-07-30
08:00 am
N/A
N/A
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
255,094 $0 0
(Indirect)
View
2020-07-28
Conversion
2020-07-30
08:00 am
N/A
N/A
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
131,645 $0 0
(Indirect)
View
2020-07-28
Conversion
2020-07-30
08:00 am
N/A
N/A
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
2,415,530 $0 0
(Indirect)
View
2020-07-28
Conversion
2020-07-30
08:00 am
N/A
N/A
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
128,384 $0 0
(Indirect)
View
2020-07-28
Conversion
2020-07-30
08:00 am
N/A
N/A
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
47,674 $0 0
(Indirect)
View
2020-07-28
Conversion
2020-07-30
08:00 am
N/A
N/A
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
4,211,330 $0 0
(Indirect)
View
2020-07-28
Conversion
2020-07-30
08:00 am
N/A
N/A
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
2,361,805 $0 0
(Indirect)
View
2020-07-28
Conversion
2020-07-30
08:00 am
N/A
N/A
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
157,529 $0 0
(Indirect)
View
2020-07-28
Conversion
2020-07-30
08:00 am
N/A
N/A
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
81,295 $0 0
(Indirect)
View
2020-07-28
Conversion
2020-07-30
08:00 am
N/A
N/A
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
1,491,666 $0 0
(Indirect)
View
2020-07-28
Conversion
2020-07-30
08:00 am
N/A
N/A
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
79,281 $0 0
(Indirect)
View
2020-07-28
Conversion
2020-07-30
08:00 am
N/A
N/A
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
29,440 $0 0
(Indirect)
View
2020-07-28
Conversion
2020-07-30
08:00 am
N/A
N/A
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
2,600,628 $0 0
(Indirect)
View
2020-07-29
Option Award
2020-07-31
6:34 pm
N/A
2030-07-29
Allovir Inc. ALVR GADICKE ANSBERT
Director
10% Owner
22,500 $0 22,500
(Direct)
View
2020-08-03
Conversion
2020-08-05
9:50 pm
N/A
N/A
Allovir Inc. ALVR GADICKE ANSBERT
Director
10% Owner
13,420,970 $0 13,420,970
(Indirect)
View
2020-08-03
Conversion
2020-08-05
9:50 pm
N/A
N/A
Allovir Inc. ALVR GADICKE ANSBERT
Director
10% Owner
20,000,000 $0 0
(Indirect)
View
2020-09-21
Conversion
2020-09-23
7:12 pm
N/A
N/A
Dyne Therapeutics Inc. DYN MPM BIOVENTURES 2018 L.P.
MPM BIOVENTURES 2018 (B) L.P.
MPM ASSET MANAGEMENT INVESTORS BV2018 LLC
MPM BioVentures 2018 GP LLC
MPM BioVentures 2018 LLC
EVNIN LUKE
Foley Todd
GADICKE ANSBERT
10% Owner
4,614,943 $0 4,614,943
(Indirect)
View
2020-09-21
Conversion
2020-09-23
7:12 pm
N/A
N/A
Dyne Therapeutics Inc. DYN MPM BIOVENTURES 2018 L.P.
MPM BIOVENTURES 2018 (B) L.P.
MPM ASSET MANAGEMENT INVESTORS BV2018 LLC
MPM BioVentures 2018 GP LLC
MPM BioVentures 2018 LLC
EVNIN LUKE
Foley Todd
GADICKE ANSBERT
10% Owner
245,279 $0 245,279
(Indirect)
View
2020-09-21
Conversion
2020-09-23
7:12 pm
N/A
N/A
Dyne Therapeutics Inc. DYN MPM BIOVENTURES 2018 L.P.
MPM BIOVENTURES 2018 (B) L.P.
MPM ASSET MANAGEMENT INVESTORS BV2018 LLC
MPM BioVentures 2018 GP LLC
MPM BioVentures 2018 LLC
EVNIN LUKE
Foley Todd
GADICKE ANSBERT
10% Owner
91,081 $0 91,081
(Indirect)
View
2020-09-21
Conversion
2020-09-23
7:12 pm
N/A
N/A
Dyne Therapeutics Inc. DYN MPM BIOVENTURES 2018 L.P.
MPM BIOVENTURES 2018 (B) L.P.
MPM ASSET MANAGEMENT INVESTORS BV2018 LLC
MPM BioVentures 2018 GP LLC
MPM BioVentures 2018 LLC
EVNIN LUKE
Foley Todd
GADICKE ANSBERT
10% Owner
13,980,992 $0 0
(Indirect)
View
2020-09-21
Conversion
2020-09-23
7:12 pm
N/A
N/A
Dyne Therapeutics Inc. DYN MPM BIOVENTURES 2018 L.P.
MPM BIOVENTURES 2018 (B) L.P.
MPM ASSET MANAGEMENT INVESTORS BV2018 LLC
MPM BioVentures 2018 GP LLC
MPM BioVentures 2018 LLC
EVNIN LUKE
Foley Todd
GADICKE ANSBERT
10% Owner
743,076 $0 0
(Indirect)
View
2020-09-21
Conversion
2020-09-23
7:12 pm
N/A
N/A
Dyne Therapeutics Inc. DYN MPM BIOVENTURES 2018 L.P.
MPM BIOVENTURES 2018 (B) L.P.
MPM ASSET MANAGEMENT INVESTORS BV2018 LLC
MPM BioVentures 2018 GP LLC
MPM BioVentures 2018 LLC
EVNIN LUKE
Foley Todd
GADICKE ANSBERT
10% Owner
275,932 $0 0
(Indirect)
View
2020-09-21
Conversion
2020-09-23
7:12 pm
N/A
N/A
Dyne Therapeutics Inc. DYN MPM BIOVENTURES 2018 L.P.
MPM BIOVENTURES 2018 (B) L.P.
MPM ASSET MANAGEMENT INVESTORS BV2018 LLC
MPM BioVentures 2018 GP LLC
MPM BioVentures 2018 LLC
EVNIN LUKE
Foley Todd
GADICKE ANSBERT
10% Owner
1,326,313 $0 0
(Indirect)
View
2020-09-21
Conversion
2020-09-23
7:12 pm
N/A
N/A
Dyne Therapeutics Inc. DYN MPM BIOVENTURES 2018 L.P.
MPM BIOVENTURES 2018 (B) L.P.
MPM ASSET MANAGEMENT INVESTORS BV2018 LLC
MPM BioVentures 2018 GP LLC
MPM BioVentures 2018 LLC
EVNIN LUKE
Foley Todd
GADICKE ANSBERT
10% Owner
70,492 $0 0
(Indirect)
View
2020-09-21
Conversion
2020-09-23
7:12 pm
N/A
N/A
Dyne Therapeutics Inc. DYN MPM BIOVENTURES 2018 L.P.
MPM BIOVENTURES 2018 (B) L.P.
MPM ASSET MANAGEMENT INVESTORS BV2018 LLC
MPM BioVentures 2018 GP LLC
MPM BioVentures 2018 LLC
EVNIN LUKE
Foley Todd
GADICKE ANSBERT
10% Owner
26,176 $0 0
(Indirect)
View
2020-10-06
Conversion
2020-10-08
6:28 pm
N/A
N/A
Oncorus Inc. ONCR GADICKE ANSBERT
10% Owner
1,783,879 $0 1,899,702
(Indirect)
View
2020-10-06
Conversion
2020-10-08
6:28 pm
N/A
N/A
Oncorus Inc. ONCR GADICKE ANSBERT
10% Owner
1,525,348 $0 1,525,348
(Indirect)
View
2020-10-06
Conversion
2020-10-08
6:28 pm
N/A
N/A
Oncorus Inc. ONCR GADICKE ANSBERT
10% Owner
775,975 $0 2,675,677
(Indirect)
View
2020-10-06
Conversion
2020-10-08
6:28 pm
N/A
N/A
Oncorus Inc. ONCR GADICKE ANSBERT
10% Owner
700,453 $0 2,225,801
(Indirect)
View
2020-10-06
Conversion
2020-10-08
6:28 pm
N/A
N/A
Oncorus Inc. ONCR GADICKE ANSBERT
10% Owner
1,783,879 $0 0
(Indirect)
View
2020-10-06
Conversion
2020-10-08
6:28 pm
N/A
N/A
Oncorus Inc. ONCR GADICKE ANSBERT
10% Owner
1,525,348 $0 0
(Indirect)
View
2020-10-06
Conversion
2020-10-08
6:28 pm
N/A
N/A
Oncorus Inc. ONCR GADICKE ANSBERT
10% Owner
775,975 $0 0
(Indirect)
View
2020-10-06
Conversion
2020-10-08
6:28 pm
N/A
N/A
Oncorus Inc. ONCR GADICKE ANSBERT
10% Owner
700,453 $0 0
(Indirect)
View
2020-07-23
Option Award
2020-10-21
4:56 pm
N/A
2030-07-23
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
Director
10% Owner
16,608 $0 0
(Direct)
View
2021-01-12
Other
2021-01-14
5:51 pm
N/A
N/A
Cullinan Management Inc. CGEM GADICKE ANSBERT
Director
10% Owner
281,268 $0 281,268
(Direct)
View
2021-01-12
Conversion
2021-01-14
5:51 pm
N/A
N/A
Cullinan Management Inc. CGEM GADICKE ANSBERT
Director
10% Owner
1,136,525 $0 1,136,525
(Indirect)
View
2021-01-12
Conversion
2021-01-14
5:51 pm
N/A
N/A
Cullinan Management Inc. CGEM GADICKE ANSBERT
Director
10% Owner
3,551,640 $0 4,688,165
(Indirect)
View
2021-01-12
Conversion
2021-01-14
5:51 pm
N/A
N/A
Cullinan Management Inc. CGEM GADICKE ANSBERT
Director
10% Owner
2,276,692 $0 6,964,857
(Indirect)
View
2021-01-12
Conversion
2021-01-14
5:51 pm
N/A
N/A
Cullinan Management Inc. CGEM GADICKE ANSBERT
Director
10% Owner
649,030 $0 7,613,887
(Indirect)
View
2021-01-12
Other
2021-01-14
5:51 pm
N/A
N/A
Cullinan Management Inc. CGEM GADICKE ANSBERT
Director
10% Owner
1,136,525 $0 1,136,525
(Indirect)
View
2021-01-12
Other
2021-01-14
5:51 pm
N/A
N/A
Cullinan Management Inc. CGEM GADICKE ANSBERT
Director
10% Owner
3,551,640 $0 3,551,640
(Indirect)
View
2021-01-12
Other
2021-01-14
5:51 pm
N/A
N/A
Cullinan Management Inc. CGEM GADICKE ANSBERT
Director
10% Owner
2,276,692 $0 2,276,692
(Indirect)
View
2021-01-12
Other
2021-01-14
5:51 pm
N/A
N/A
Cullinan Management Inc. CGEM GADICKE ANSBERT
Director
10% Owner
649,030 $0 649,030
(Indirect)
View
2021-01-12
Other
2021-01-14
5:51 pm
N/A
2030-10-28
Cullinan Management Inc. CGEM GADICKE ANSBERT
Director
10% Owner
262,114 $0 262,114
(Direct)
View
2021-01-12
Other
2021-01-14
5:51 pm
N/A
2030-10-28
Cullinan Management Inc. CGEM GADICKE ANSBERT
Director
10% Owner
88,824 $0 88,824
(Direct)
View
2021-01-12
Conversion
2021-01-14
5:51 pm
N/A
N/A
Cullinan Management Inc. CGEM GADICKE ANSBERT
Director
10% Owner
1,136,525 $0 0
(Indirect)
View
2021-01-12
Conversion
2021-01-14
5:51 pm
N/A
N/A
Cullinan Management Inc. CGEM GADICKE ANSBERT
Director
10% Owner
3,551,640 $0 0
(Indirect)
View
2021-01-12
Conversion
2021-01-14
5:51 pm
N/A
N/A
Cullinan Management Inc. CGEM GADICKE ANSBERT
Director
10% Owner
2,276,692 $0 0
(Indirect)
View
2021-01-12
Conversion
2021-01-14
5:51 pm
N/A
N/A
Cullinan Management Inc. CGEM GADICKE ANSBERT
Director
10% Owner
649,030 $0 0
(Indirect)
View
2021-01-20
Other
2021-01-22
8:16 pm
N/A
N/A
Harpoon Therapeutics Inc. HARP MPM BioVentures 2014 L.P.
MPM ASSET MANAGEMENT LLC
MPM BioVentures 2014 (B) L.P.
MPM Asset Management Investors BV2014 LLC
MPM BioVentures 2014 LLC
MPM BioVentures 2014 GP LLC
Foley Todd
GADICKE ANSBERT
EVNIN LUKE
10% Owner
101,646 $0 4,405,085
(Indirect)
View
2021-03-12
Other
2021-03-15
5:10 pm
N/A
N/A
Repare Therapeutics Inc. RPTX GADICKE ANSBERT
10% Owner
24,271 $0 4,672,838
(Indirect)
View
2021-04-07
Other
2021-04-09
4:47 pm
N/A
N/A
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management GP LLC
10% Owner
15,670 $0 6,036,872
(Indirect)
View
2021-05-04
Conversion
2021-05-06
4:19 pm
N/A
N/A
Werewolf Therapeutics Inc. HOWL GADICKE ANSBERT
MPM ONCOLOGY INNOVATIONS FUND LP
UBS Oncology Impact Fund L.P.
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Innovations Fund GP LLC
MPM Oncology Impact Management GP LLC
10% Owner
4,477,742 $0 4,939,150
(Indirect)
View
2021-05-04
Conversion
2021-05-06
4:19 pm
N/A
N/A
Werewolf Therapeutics Inc. HOWL GADICKE ANSBERT
MPM ONCOLOGY INNOVATIONS FUND LP
UBS Oncology Impact Fund L.P.
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Innovations Fund GP LLC
MPM Oncology Impact Management GP LLC
10% Owner
1,488,033 $0 6,427,183
(Indirect)
View
2021-05-04
Conversion
2021-05-06
4:19 pm
N/A
N/A
Werewolf Therapeutics Inc. HOWL GADICKE ANSBERT
MPM ONCOLOGY INNOVATIONS FUND LP
UBS Oncology Impact Fund L.P.
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Innovations Fund GP LLC
MPM Oncology Impact Management GP LLC
10% Owner
38,818,000 $0 0
(Indirect)
View
2021-05-04
Conversion
2021-05-06
4:19 pm
N/A
N/A
Werewolf Therapeutics Inc. HOWL GADICKE ANSBERT
MPM ONCOLOGY INNOVATIONS FUND LP
UBS Oncology Impact Fund L.P.
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Innovations Fund GP LLC
MPM Oncology Impact Management GP LLC
10% Owner
12,899,925 $0 0
(Indirect)
View